Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Tax Provisions: 2023-2024

Historic Tax Provisions for Krystal Biotech (KRYS) over the last 2 years, with Dec 2024 value amounting to $6.2 million.

  • Krystal Biotech's Tax Provisions fell 1307.69% to -$31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.0 million, marking a year-over-year change of. This contributed to the annual value of $6.2 million for FY2024, which is 215.37% up from last year.
  • Krystal Biotech's Tax Provisions amounted to $6.2 million in FY2024, which was up 215.37% from $2.0 million recorded in FY2023.
  • Krystal Biotech's Tax Provisions' 5-year high stood at $6.2 million during FY2024, with a 5-year trough of $2.0 million in FY2023.
  • Moreover, its 2-year median value for Tax Provisions was $4.1 million (2023), whereas its average is $4.1 million.
  • Data for Krystal Biotech's Tax Provisions shows a peak YoY skyrocketed of 215.37% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Krystal Biotech's Tax Provisions stood at $2.0 million in 2023, then skyrocketed by 215.37% to $6.2 million in 2024.